Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
Clinical trial NCT01187199 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01187199
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-19
- Primary completion
- 2026-04-30
- Enrollment
- 278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.